Skip to content
Open access

De novo L-(+)-tartaric acid biosynthesis in multi-modular engineered yeasts

Aug 2026 · Nature Communications · Vol 17 · 0 citations · 61 references
Medicine

Abstract

L-(+)-tartaric acid (L-TA) is a high-value chiral organic acid essential for food and pharmaceuticals. Despite its industrial importance, sustainable green production is constrained by the lack of a fully defined biosynthetic pathway. Here, we report the de novo biosynthesis of L-TA in Saccharomyces cerevisiae through reaction-guided enzyme mining, experimental validation, and Enzyme Commission-specific Catalytic Hybrid Optimizer (ECHO)-assisted enzyme prioritization. We first elucidate the elusive two-step conversion from precursor 5-keto-D-gluconic acid (5-KGA) to L-TA, catalyzed by transketolase (TK) and succinate semialdehyde dehydrogenase (SSDH). To optimize this critical step, we develop the ECHO. This multimodal framework integrates sequence, substrate, and pocket-aware structural information to identify high-performance TK-SSDH pairs. By integrating this pathway with de novo precursor synthesis, cofactor engineering, and semi-rational protein engineering, a final L-TA titer of 6.59 mg L−1 was achieved in a 5-L bioreactor. By connecting computational mining and metabolic assembly through a multi-module engineering strategy, our study establishes a green platform for L-TA production and demonstrates an effective workflow for synthetic pathway design. L-(+)-tartaric acid (L-TA) is a high-value chiral organic acid for food and pharmaceuticals. Here the authors produce L-TA in S. cerevisiae through reaction-guided enzyme mining and Enzyme Commission-specific Catalytic Hybrid Optimizer (ECHO)-assisted enzyme prioritization.

Read PDF

Similar papers

Sep 2026

Efficient Production of Vanillyl Alcohol in Escherichia coli via Protein and Pathway Engineering

Vanillyl alcohol (VNA) is a high-value compound used in the pharmaceutical industry and other fields. Its microbial de novo biosynthesis is severely limited by the low catalytic efficiency of O-methyltransferase. Here, we constructed a V314I mutant of caffeate O-methyltransferase via structure-guided protein engineer...

Jin-Yi Li, Yong Du, Jia Wang et al. · 0 citations
Sep 2026

Metabolic engineering of Saccharomyces cerevisiae for the biosynthesis of indole-derived compounds.

Indole-3-acetonitrile (IAN) and its derivatives-indole-3-carboxaldehyde (I3A), indole-3-carboxylic acid (I3CA), and 3,3'-diindolylmethane (DIM)-are high-value indole-derived compounds widely used in the chemical, pharmaceutical, and nutraceutical industries. However, their de novo microbial production has not yet been...

Meng-Chu Sun, Xiao-Lin Shen, Xin-Xiao Sun et al. · 0 citations
Aug 2026

Valorizing Non-Food Carbon Sources: Discovery and Characterization of a Cyberlindnera jadinii for Single-Cell Protein Synthesis

This GRAS-certified platform establishes a highly efficient and economically viable route for the sustainable production of high-value SCP from non-food substrates, and validate a circular bioeconomy model by converting electrochemically synthesized 13C-labeled acetate into SCP.

Wei Zhong, Chong Xie, Kuan Chen et al. · 0 citations
Sep 2026

Engineering the Metabolic Pathway of Escherichia coli for Efficient Biosynthesis of Lacto- N -tetraose

Lacto-N-tetraose (LNT), a core component of human milk oligosaccharides (HMOs), plays essential biological roles; however, its production remains challenging due to low conversion efficiency and the accumulation of intermediates. In this study, a systematic metabolic engineering strategy was applied to Escherichia co...

Miaomiao Hu, Shu-Fang Qin, Yi-Lu Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.